Âé¶¹´«Ã½Ó³»­

Âé¶¹´«Ã½Ó³»­

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Development of a structured process for the Spanish translation of the 2021 ACNS standardized critical care EEG terminology
Global Health and Neuroepidemiology
P4 - Poster Session 4 (8:00 AM-9:00 AM)
10-010
To develop a Spanish translation of the 2021 critical care EEG terminology through  a structured consensus of an interdisciplinary group with representation from Latin America and Spain. 

Aiming for a common language for the classification of electroencephalogram (EEG) findings in critical care (ICU), the American Clinical Neurophysiology Society (ACNS) published the ICU-EEG terminology in 2013, which was updated in 2021. Since this nomenclature has not been published in Spanish, the potential use of the ICU-EEG terminology can be variable when translated into daily practice in Spanish-speaking countries.   

The initial translation of the terminology was done in parallel by three subgroups of Spanish-speaking neurophysiologists and neurointensivists representing different regions of Latin America and Spain. Each subgroup worked iteratively on one section of the terminology. Scheduled meetings were carried out with the entire team to discuss translation differences and alternatives, which were recorded for discussion in future planned consensus groups. We have recruited 25 participants from Latin America and Spain to explore their impressions on the applicability, implementation, and regional differences of the translation in different Spanish-speaking countries. Using qualitative methodology, the consensus groups will follow nominal group technique methods.

The process, common discussion points, and consensus agreements and disagreements of the different terms chosen in the translation will be presented.

The Spanish language is diverse, and the terms used to describe electroencephalographic findings vary in different countries. It is essential to consider these variations when translating guidelines into other languages. Translations need to be structured, iterative, and consensus-based with representations of different countries with the same language to encourage widespread use and a more homogeneous communication, which can in turn facilitate and encourage future research.

Authors/Disclosures
Maria J. Bruzzone, MD, FÂé¶¹´«Ã½Ó³»­ (University of Florida)
PRESENTER
Dr. Bruzzone has nothing to disclose.
Clio A. Rubinos, MD, MSCR (University of North Carolina) Dr. Rubinos has nothing to disclose.
Andrea R. Lowden, MD (University of Texas Southwestern) Dr. Lowden has nothing to disclose.
Juan Appendino, MD Dr. Appendino has nothing to disclose.
Jorge A. Vidaurre, MD (Nationwide Children's Hospital - OSU) Dr. Vidaurre has nothing to disclose.
Daniel San Juan-Orta Daniel San Juan-Orta has nothing to disclose.
Naiara Garcia Losarcos, MD (University Hospitals) Dr. Garcia Losarcos has nothing to disclose.
Mauricio F. Villamar, MD, FÂé¶¹´«Ã½Ó³»­ (Department of Neurology, The Warren Alpert Medical School of Brown University) Dr. Villamar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ceribell. Dr. Villamar has or had stock in Ceribell.Dr. Villamar has received research support from Brown Physicians Inc.. Dr. Villamar has a non-compensated relationship as a Member of Editorial Board with Neurology: Clinical Practice that is relevant to Âé¶¹´«Ã½Ó³»­ interests or activities. Dr. Villamar has a non-compensated relationship as a Member of Editorial Board with The Neurohospitalist that is relevant to Âé¶¹´«Ã½Ó³»­ interests or activities. Dr. Villamar has a non-compensated relationship as a Co-Chair - Quality Improvement Committee with American Clinical Neurophysiology Society that is relevant to Âé¶¹´«Ã½Ó³»­ interests or activities. Dr. Villamar has a non-compensated relationship as a Co-Leader, Practice and Compensation Survey Working Group with The Neurohospitalist Society that is relevant to Âé¶¹´«Ã½Ó³»­ interests or activities.
Jorge G. Burneo, MD, MSPH, FÂé¶¹´«Ã½Ó³»­ (University of Western Ontario) Dr. Burneo has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier, Clinical Neurology and Neurosurgery Journal. Dr. Burneo has received research support from The Jack Cowin Endowed Chair in Epilepsy Research. Dr. Burneo has received publishing royalties from a publication relating to health care. Dr. Burneo has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Jazz Pharmaceuticals.
Luis C. Mayor-Romero, MD (Hospital Universitario Fundacion Santa Fe De Bogot) Dr. Mayor-Romero has nothing to disclose.
Andres Rodriguez-Ruiz, MD (Emory University) Dr. Rodriguez-Ruiz has received personal compensation in the range of $0-$499 for serving as a Consultant for Atheneum. Dr. Rodriguez-Ruiz has stock in Lourbeth LLC.
Camilo A. Gutierrez, MD, FÂé¶¹´«Ã½Ó³»­ (University of Maryland) Dr. Gutierrez has nothing to disclose.
Andres Fernandez, MD (Thomas Jefferson University Hospital) Dr. Fernandez has nothing to disclose.